Blood products are a vital part of the healthcare system, and we are proud to partner with local hospitals in our communities to strengthen patient care. We proudly provide blood products to more than 244 hospitals across Oklahoma, Texas and Arkansas.
Our Blood Institute is pleased to work with healthcare providers to fulfill specialized blood collection needs. These services include Therapeutic phlebotomy, as well as Autologous and Directed donations. We currently only accept orders/requests electronically. Please use the following link to access our Special Donations page and form links.
Click the link below to see a list of hospitals where patients rely exclusively on Our Blood Institute's volunteer donors for all blood needed.
To learn more about partnering with our organization, contact a member of our Client Relations team:
randy.petty@obi.org | 405-297-3118
shannon.davis@obi.org | 405-471-3612
david.alters@obi.org | 405-297-5524
Check out these digital resources to advocate for the health of the blood supply and local patients.
Use these materials to help demonstrate the need for Group O blood donors and spread the word about giving blood. Every post and email you share will contribute to lives being saved.
The Reference Laboratory provides specialized testing on blood products to identify and supply rare blood products to those in need. Everyone has a specific set of antigens in their blood, some of which can be rare. If enough antigens are present, the patient will require a unit of blood from a donor who matches their unique profile. That’s where we come in!
With every donation, our diligent laboratory staff performs dozen of tests to ensure blood products are safe and ready to be transfused to local patients. As a fully-licensed and certified laboratory, we maintain the highest standards and lead the nation in applying cutting-edge technology to create the safest blood products possible.
The Circular of Information for the Use of Human Blood and Blood Components (“the Circular”) serves as an extension of the product label, providing indications for the use of blood and blood components, precautions, instructions for administration, and adverse effects of transfusion. It is recognized by the Food and Drug Administration as an acceptable extension of container labels. Like a package insert for prescription drugs, it is an important part of the labeling of a blood component. The Code of Federal Regulations, Title 21, requires it to be available for distribution with blood and blood components intended for transfusion.
